During the past decade, Clinique Mutualiste de l'Estuaire conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Mutualiste de l'Estuaire" #1 sponsor was "UNICANCER" with 6 trials, followed by "ARCAGY/ GINECO GROUP" with 4 trials sponsored, "Centre Hospitalier Departemental Vendee" with 3 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 3 trials sponsored and "Centre Leon Berard" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Mutualiste de l'Estuaire" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Mutualiste de l'Estuaire" are "Breast Cancer" (3 trials), "Non-small Cell Lung Cancer Metastatic" (2 trials), "Ovarian Cancer" (2 trials), "ALK Gene Rearrangement Positive" (1 trials) and "Adenocarcinoma of Lung Metastatic to Brain" (1 trials). Many other conditions were trialed in "Clinique Mutualiste de l'Estuaire" in a lesser frequency.

Most popular intervention types in "Clinique Mutualiste de l'Estuaire" are "Drug" (25 trials), "Other" (4 trials), "Radiation" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (4 trials), "Pemetrexed" (3 trials), "Gemcitabine" (2 trials), "Irinotecan" (2 trials) and "5 FU bolus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Mutualiste de l'Estuaire" are 20 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Mutualiste de l'Estuaire". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Clinique Mutualiste de l'Estuaire, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Mutualiste de l'Estuaire, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".